Dr. Vijaykumar N. Roy, MD

Dr. Roy practices at Hmhmg Specialty Care in Hackensack, New Jersey.

Dr. Roy's NPI, 1982688925, was assigned on December 2, 2005. Dr. Roy graduated from N.H.L Municipal Medical College in 1981. Dr. Roy holds New Jersey license MA047133.

Dr. Roy's primary practice is Hmhmg Specialty Care, at 360 Essex St Ste 401 Suite 401, Hackensack, NJ 07601. The practice phone is (551) 996-1140.

Dr. Roy's primary practice is Hmhmg Specialty Care in Hackensack, New Jersey. Dr. Roy is also affiliated with Hackensack University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Roy to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roy practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Roy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Roy is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Roy's licenses on file in 5 states: New Jersey, Illinois, Indiana, Pennsylvania and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Roy treats.

CMS data shows 72,381 Medicare services from Dr. Roy across 15 procedure codes in 2024, for 263 Medicare patients. Medicare paid $364,446 for them. Every service was in an office.

CMS counts 263 Medicare patients who saw Dr. Roy in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roy's median patient age at 69, with 60% women.

In 2024, Dr. Roy wrote 700 Medicare Part D claims for 97 patients. 57% of them were for generic drugs. CMS names the drug for 542 of them, across 23 drugs with 11 or more claims each, at $3,215,080 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Roy for performance year 2024, reported individually. Dr. Roy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 89 general payments to Dr. Roy from 24 drug and device companies in 2025. Food and beverage make up the largest share, 85% of the total. Bristol-Myers Squibb Company paid the most, $274.

Dr. Roy graduated from N.H.L Municipal Medical College in 1981.

Dr. Roy is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.